Ledger.Open graph →

SEC Form D · filed October 16, 2015

Transplant Genomics Inc

Offering

$3.0M

Sold

$1.2M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BROOKLINE, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Roy First · Brookline, MAExec Darren Lee · Brookline, MAExec Stanley Rose · Brookline, MAExec · Director Daniel Salomon · Brookline, MADirector Brett Jensen · Brookline, MAExec Kyle Hart · Brookline, MAExec Dierdre Pierry · Brookline, MAExec Michael Abecassis · Brookline, MADirector James W. Emlen · Aurora, COExec Richard C. Duke · Aurora, COExec John P. Talbott · Bondi, Channel IslandsDirector Debra M. Duke · Aurora, COExec Faouzi Sefrioui · Woodinville, WADirector T. R. Fort · Aurora, COExec Derek Hoiem · Champaign, ILExec Vernon W. Bryant, Jr · Fort Worth, TXExec · Director Saladin El Ayoubi · Seattle, WADirector Jeffrey P. Beyer · Portland, ORDirector Lisanne T. Davidson · Fort Worth, TXExec · Director James S. Crigler · Dallas, TXExec Gabriel S. Hidalgo · Dallas, TXExec Tina S. Hou · Dallas, TXExec Harish Abbott · San Francisco, CAExec Ajay Agarwal · San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗